Fiche publication


Date publication

mars 2026

Journal

Cornea

Auteurs

Membres identifiés du Cancéropôle Est :
Dr GOETZ Christophe


Tous les auteurs :
Delean S, Goetz C, Zevering Y, Perone JM

Résumé

Descemet membrane endothelial keratoplasty (DMEK) is the gold standard treatment for Fuchs endothelial corneal dystrophy (FECD). It is generally conducted mo/yr or immediately after lens phacoemulsification (pseudophakic-DMEK and triple-DMEK, respectively). A recent meta-analysis reported that mean central corneal thickness (CCT) 6 to 12 months after pseudophakic/triple-DMEK in Western European patients was 522 μm. However, mean CCT in healthy Western Europeans is 552 μm. This retrospective cohort study tested whether post-DMEK CCT in FECD eyes is thinner than normal by comparing consecutive pseudophakic/triple-DMEK eyes to consecutive cataract-surgery control eyes.

Mots clés

Descemet membrane endothelial keratoplasty, Fuchs endothelial corneal dystrophy, central corneal thickness, phacoemulsification, pseudophakic-DMEK, triple-DMEK

Référence

Cornea. 2026 03 11;: